Leishmaniasis phytotherapy. Nature's leadership against an ancient disease (Q34360452)

1 August 2017

1 reference

title

Leishmaniasis phytotherapy. Nature's leadership against an ancient disease (English)

1 reference

1 August 2017

de Carvalho PB

1

1 reference

PubMed ID

11543959

1 August 2017

Ferreira EI

series ordinal

2

1 reference

1 August 2017

1 August 2001

1 reference

1 August 2017

20

1 reference

inferred from page(s)

published in

Fitoterapia

1 reference

1 August 2017

72

1 reference

1 August 2017

6

1 reference

1 August 2017

599-618

1 reference

Leishmaniases of the New World: current concepts and implications for future research

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

Epidemiology of the leishmaniases.

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

Apparently successful treatment of two cases of post kala-azar dermal leishmaniasis with liposomal amphotericin B

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

Post-kala-azar dermal leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

Visceral infection caused by Leishmania tropica in veterans of Operation Desert Storm

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

Phlebotomine vectors of the leishmaniases: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

Canine leishmaniasis in Morocco with special reference to infantile kala-azar

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

Application of a direct agglutination test for detection of specific anti-Leishmania antibodies in the canine reservoir

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

Preliminary serological study on canine leishmaniasis in the Alpes-Martimes Département, France

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

Visceral leishmaniasis: more prevalent and more problematic

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

Molecular population genetic analysis of emerged bacterial pathogens: selected insights

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

Could infected drug-users be potential Leishmania infantum reservoirs?

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

Visceral leishmaniasis in a child with HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

Don't forget visceral leishmaniasis in transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

Leishmaniosis--new perspectives on an underappreciated opportunistic infection

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

Generalized cutaneous leishmaniasis in acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

Visceral leishmaniasis in patients infected with the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

A cloned antigen (recombinant K39) of Leishmania chagasi diagnostic for visceral leishmaniasis in human immunodeficiency virus type 1 patients and a prognostic indicator for monitoring patients undergoing drug therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

Relapse of visceral leishmaniasis in patients who were coinfected with human immunodeficiency virus and who received treatment with liposomal amphotericin B.

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

The Brazilian Leishmaniasis Control Program

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

[Treatment of infantile visceral leishmaniasis]

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

Chemotherapy for leishmaniasis: biochemical mechanisms, clinical efficacy, and future strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

Kala-azar: current status of experimental chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

Extremely rapid endocytosis mediated by the mannose receptor of sinusoidal endothelial rat liver cells

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

Sugar receptor mediated drug delivery to macrophages in the therapy of experimental visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

Synthesis of antimony complexes of yeast mannan and mannan derivatives and their effect on Leishmania-infected macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

Mannose-coated liposomal hamycin in the treatment of experimental leishmaniasis in hamsters

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

The mannose receptor is a pattern recognition receptor involved in host defense

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

The role of interferon-gamma in the treatment of visceral and diffuse cutaneous leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

Effect of Treatment with Interferon- Alone in Visceral Leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

Phase 1 study of an inactivated vaccine against American tegumentary leishmaniasis in normal volunteers in Brazil

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

A field trial of a vaccine against American dermal leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

Vaccination of C57BL/10 mice against cutaneous leishmaniasis. Use of purified gp63 encapsulated into niosomes surfactants vesicles: a novel approach

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

Access to essential drugs in poor countries: a lost battle?

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

Medicinal plants and the control of protozoal disease, with particular reference to malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

Plants used in the treatment of leishmanial ulcers due to Leishmania (Viannia) braziliensis in an endemic area of Bahia, Brazil

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

Medicinal plants in the fight against leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

Protein expression in yeast as an approach to production of recombinant malaria antigens.

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

A double-blind randomized clinical trial of a topical herbal extract (Z-HE) vs. systemic meglumine antimoniate for the treatment of cutaneous leishmaniasis in Iran

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

Evaluation of plant extracts for antileishmanial activity using a mechanism-based radiorespirometric microtechnique (RAM)

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

Pessoine and spinosine, two catecholic berbines from Annona spinescens

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

Antiprotozoal agents from plant sources

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

Two new antiprotozoal 5-methylcoumarins from Vernonia brachycalyx

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

Leishmanicidal and trypanocidal activities of Bolivian medicinal plants

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

[Active antihelminitic alkaloids: active in vitro against Leishmanic Tropica the protozoa involved in leishmaniasis.]

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

2-substituted quinoline alkaloids as potential antileishmanial drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

The effect of some 2-substituted quinolines isolated from Galipea longiflora on Plasmodium vinckei petteri infected mice

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

In vivo efficacy of oral and intralesional administration of 2-substituted quinolines in experimental treatment of new world cutaneous leishmaniasis caused by Leishmania amazonensis

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

New aporphine alkaloids from guatteria foliosa

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

Antileishmanial activity of a tetralone isolated from Ampelocera edentula, a Bolivian plant used as a treatment for cutaneous leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

Isolation of bis-indole alkaloids with antileishmanial and antibacterial activities from Peschiera van heurkii (syn. Tabernaemontana van heurkii)

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

Biological and chemical studies of Pera benensis, a Bolivian plant used in folk medicine as a treatment of cutaneous leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

Acetogenins and other compounds from Rollinia emarginata and their antiprotozoal activities

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

Cytotoxic and antiparasitic activity from Annona senegalensis seeds

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

A novel leishmanicidal labdane from Polyalthia macropoda

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

Pine needle abortion in cattle: metabolism of isocupressic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

Licochalcone A, a novel antiparasitic agent with potent activity against human pathogenic protozoan species of Leishmania

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

An Antileishmanial Chalcone from Chinese Licorice Roots

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

Isolation of flavins from the Amazonian shrub Faramea guianesis

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

Biological activity of saponins from two Dracaena species

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

Antiprotozoal compounds from Asparagus africanus.

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

Antiprotozoal activity of aporphine alkaloids isolated from Unonopsis buchtienii (Annonaceae).

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

Selective effect of 2',6'-dihydroxy-4'-methoxychalcone isolated from Piper aduncum on Leishmania amazonensis

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

Diospyrin, a bisnaphthoquinone: a novel inhibitor of type I DNA topoisomerase of Leishmania donovani

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

A novel antiprotozoal aminosteroid from Saracha punctata

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

Cytotoxic and leishmanicidal aminoglycosteroids and aminosteroids from Holarrhena curtisii

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

Leishmanicidal activity of 2-benzoxazolinone from Acanthus illicifolius in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

Saponins of the ivy plant, Hedera helix, and their leishmanicidic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

[Isolation and synthesis of espintanol, a new antiparasitic monoterpene]

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

Leishmanicidal activity of combretastatin analogues and heteroanalogues

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

Experimental treatment of cutaneous leishmaniasis with argentilactone isolated from Annona haematantha.

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

Amarogentin, a naturally occurring secoiridoid glycoside and a newly recognized inhibitor of topoisomerase I from Leishmania donovani.

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

Iridoids: a new class of leishmanicidal agents from Nyctanthes arbortristis

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

[An evaluation of the effect of a bark extract from the cashew (Anacardium occidentale L.) on infection by Leishmania (Viannia) braziliensis]

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

The failure of traditionally used desert plants to act against cutaneous leishmaniasis in experimental animals.

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

Antiprotozoal properties of 16,17-dihydrobrachycalyxolide from Vernonia brachycalyx

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

Protective effect of Picroliv from Picrorhiza kurroa against Leishmania donovani infections in Mesocricetus auratus

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

Immunostimulant Activity of Picroliv, the Iridoid Glycoside Fraction of Picrorhiza kurroa, and its Protective Action against Leishmania donovani Infection in Hamsters1.

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

Haemolytic activities of plant saponins and adjuvants. Effect of Periandra mediterranea saponin on the humoral response to the FML antigen of Leishmania donovani

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

Macrophage activation by the polysaccharide arabinogalactan isolated from plant cell cultures of Echinacea purpurea

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

Therapeutic effect of oral Kalanchoe pinnata leaf extract in murine leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

The anti-leishmanial effect of Kalanchoe is mediated by nitric oxide intermediates.

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

Fusarium moniliforme Sheld. A fungus producing a broad spectrum of bioactive metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

Ribosome-inactivating proteins from plants inhibit ribosome activity of Trypanosoma and Leishmania

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

A new method for the partial purification of leishmania amastigotes from cutaneous lesionS.

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

Anal ulcer and chronic diarrhoea as manifestations of visceral leishmaniasis in a patient infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

Genital ulcer in an AIDS patient with disseminated leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0367-326X%2801%2900301-X

7 January 2021

10.1016/S0367-326X(01)00301-X

Identifiers

DOI

1 reference

1 August 2017

1 reference

PubMed ID

11543959